1. Home
  2. KNSA vs CAAP Comparison

KNSA vs CAAP Comparison

Compare KNSA & CAAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

HOLD

Current Price

$76.63

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Logo Corporacion America Airports SA

CAAP

Corporacion America Airports SA

HOLD

Current Price

$24.54

Market Cap

4.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
KNSA
CAAP
Founded
2015
1998
Country
United Kingdom
Luxembourg
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.5B
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
KNSA
CAAP
Price
$76.63
$24.54
Analyst Decision
Strong Buy
Buy
Analyst Count
7
3
Target Price
$60.86
$26.73
AVG Volume (30 Days)
428.4K
209.8K
Earning Date
04-28-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
225.00
N/A
EPS
0.27
N/A
Revenue
$677,564,000.00
N/A
Revenue This Year
$37.48
$5.80
Revenue Next Year
$17.87
$2.36
P/E Ratio
$290.81
$26.35
Revenue Growth
60.09
N/A
52 Week Low
$35.29
$17.36
52 Week High
$82.94
$30.50

Technical Indicators

Market Signals
Indicator
KNSA
CAAP
Relative Strength Index (RSI) 48.49 53.28
Support Level $44.95 $23.73
Resistance Level $82.25 $26.76
Average True Range (ATR) 2.37 0.79
MACD -0.80 0.13
Stochastic Oscillator 19.36 74.74

Price Performance

Historical Comparison
KNSA
CAAP

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

About CAAP Corporacion America Airports SA

Corporacion America Airports SA acquires, develops, and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador, and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.

Share on Social Networks: